Good MorningEquities pulled back again on Tuesday following another round of hotter than expected inflation data. The PPI came in at 0.8% for the month, up 0.2% from October and 0.3% hotter than forecast. The figure is coupled with high core readings and the hottest YOY increases on record.
If there was any doubt the FOMC would be raising interest rates sooner than expected this news should lay those doubts to rest. The CME Fedwatch tool is pricing in a near 60% chance the first hike will come by May and a 70% chance for two .25% interest rate hikes by June so today’s FOMC meeting is more important than ever. The Fed is expected to accelerate the taper and move the timeline for rate hikes forward.
Featured: This Single Fund Owns Every Major AI Stock and Pays Weekly (Ad) 
|
Markets | |
When you have a precise retirement savings number you'd like to achieve, it takes dedication and consistent investing to get there.
Luckily, Americans have confidence that they'll achieve their retirement goals. Three in four workers (73%) believe they can fully retire with a comfortable lifestyl... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Consumer Discretionary | | Casino operator Las Vegas Sands (NYSE: LVS) stock has fallen down to its COVID-19 low levels in recent weeks. The epicenter stock has seen renewed fears of China intervention with the Macau gambling industry as well as COVID-19 protocols tightening again. Gambling is one of the few industries that d... Read the Full Story |
|
Consumer Discretionary | |
Since the early days of the pandemic, the reopening trade has been a popular way play the anticipated turnaround in beaten up, economically sensitive stocks.
Some groups like restaurants and retailers have recovered much if not all of their 2020 losses. Others like airlines and hotels have many m... Read the Full Story |
|
From Our Partners | | Tobacco, telecom, pipelines, and healthcare real estate trade at 10 to 15 times earnings while the index yields about 1 percent.
A free report highlights seven cash-generating stocks with a 5 percent forward yield floor and roughly 6.5 percent average cash yield, capped at two picks per sector.
Each pick includes coverage numbers and an honest bear case. Five of the seven have raised payouts for 17 to 56 straight years. | | Get the seven high-yield dividend stocks free now |
|
Technology | |
Just when many companies began anticipating welcoming employees back to the office, the Omicron variant has caused some to reconsider. Google (NASDAQ:GOOGL) and Ford (NYSE:F) are two examples of companies that just announced they are delaying their return-to-work plans.
But the repercussions of... Read the Full Story |
|
Healthcare | |
3 Low-Volatility Stocks Showing Strength in a Weak Market
Market sentiment can change in the blink of an eye, and that’s quite evident in the recent selling pressure we’ve seen occurring in the high growth areas. A lot of this likely has to do with the upcoming Federal Reserve meeting... Read the Full Story |
|
|
Consumer Discretionary | |
Rivian or Lucid Motors, Both Look Good For the Long Haul, Which is Best Right Now?
Electric vehicle (EV) stocks remain one of the most intriguing plays for investors. After a sharp sell-off earlier this year, stocks of EV companies are beginning to reinflate. And two of the hottest stocks in the ... Read the Full Story |
|
Markets | |
It’s Time To Get Ready For Q4 2021 Earnings
With the S&P 500 (NYSEARCA: SPY) Q4 earnings cycle having already started, it is time to get ready for the peak of the season. The peak is still quite a few weeks away but it pays to be ready. So far, reports from names like Oracle (NYSE: ORCL... Read the Full Story |
|
Markets | | Fiber optics providers Ciena (NYSE: CIEN) and Clearfield (NASDAQ: CLFD) are trading at multi-year highs as network upgrades spur revenue growth.
Although they operate in similar industries and are well established, these are quite different companies.
With a market capitalization of $11.49 billi... Read the Full Story |
|
Consumer Discretionary | |
Winnebago Is A Buy Before Earnings
To answer the question, are insiders buying Winnebago (NYSE: WGO) ahead of earnings, we must say yes, they are, or at least one did. Director Maria Favlana Blase bought 364 shares for a grand total of $24,053 at the end of October capping off a year in which mo... Read the Full Story |
|
Markets | |
Hexo Hits New Low In Wake Of Q1 Earnings
Hexo (NYSE: HEXO) reported its Q1 earnings and provided a forecast for profitability that has shares of the stock on the move. The caveat is that shares are moving lower right now and are just off the new low set in the wake of the report. As good as the ... Read the Full Story |
|
The Early Bird Stock Of The Day Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension. | | View Today's Stock Pick |
|
